IP Library Granted Patent US 10,123,938
Granted Patent B2
US 10,123,938 · App. 14/023,650 · Granted Nov 13, 2018

Method and assembly for fluid transfer and drug containment in an infusion system

Inventors: Roger Akerlund (Gothenburg, SE); Kjell Andreasson (Vastra Frolunda, SE); Petri Horppu (Gothenburg, SE)
Assignee: Carmel Pharma AB
A61J1/10A61J1/1406A61J1/1425A61J1/1481A61J1/2089A61M5/1409A61J1/1468A61J1/201A61J1/2034A61J1/2055A61M39/045A61M2039/222
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,123,938
App. No.
14/023,650
Granted
Nov 13, 2018
Kind
B2
Abstract

A fluid transfer assembly, drug container, and method for enabling fluid transfer in an infusion system is taught. The assembly includes a fluid container containing an infusion fluid, and a drug container. The fluid container has at least one inlet port for receiving a medical substance from the drug container. The assembly further includes at least one fluid barrier controlling fluid passage between the drug container and the fluid container. The inlet port exhibits a first luer-lock connector, and the drug container is sealed by a cap exhibiting a second luer-lock connector for attachment to the first luer-lock connector. The fluid barrier is designed and arranged to be ruptured by an external force to allow the fluid passage.

Claims (6)

1. A fluid transfer assembly for use in an infusion system, said assembly comprising: a fluid container having an infusion fluid, a drug container having a medical substance, said fluid container further comprising a first port for receiving said medical substance from said drug container, said drug container further comprising a cap for sealing said drug container, said first port further comprising walls being made of a flexible material, and the first port further comprises a first luer-lock connector, and wherein the walls form a first fluid duct between said fluid container and said first luer-lock connector, the first fluid duct having a first fluid barrier controlling fluid passage between said drug container and said fluid container, and said cap further comprising a second luer-lock connector for attachment to said first luer-lock connector and a protruding member forming a second fluid duct between said drug container and said second luer-lock connector, the second fluid duct having a second fluid barrier, said fluid container further comprising a second port having walls being made of a flexible material, the second port adapted for connection to an infusion line, the walls of the second port forming a third fluid duct between said fluid container and said infusion line, the third fluid duct having a third fluid barrier, wherein said first fluid barrier, second fluid barrier and third fluid barrier are designed and arranged to be ruptured by an external twisting, bending, or squeezing force to allow said fluid passage, wherein said fluid container being flexible and comprising a first polymer material, said first port and second port comprising a second polymer material, said first luer-lock connector comprising a third polymer material, and said first fluid barrier, second fluid barrier and third fluid barrier comprising a fourth polymer material, wherein said first and second polymer materials are more flexible than said third polymer material, and said fourth polymer material is more brittle than all of said first, second and third polymer materials.

2. The fluid transfer assembly according to claim 1 , wherein the second luer-lock connector is attached directly to said cap.

3. The fluid transfer assembly according to claim 1 , wherein the second luer-lock connector is an integral part of said cap.

4. The fluid transfer assembly according to claim 1 , said second luer-lock connector further comprising a removable closure for protection before use.

5. The fluid transfer assembly according to claim 1 , said drug container further comprising a neck, and said cap further comprising a protruding member attachable to said neck by an annular capsule member.

6. The fluid transfer assembly according to claim 1 , said fluid transfer assembly further comprising a first clamping member able to compress said walls forming said first fluid duct and preventing undesired fluid passage between said fluid container and said first luer-lock connector.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2018
From: AKERLUND, ROGER; HORPPU, PETRI; ANDREASSON, KJELL
To: CARMEL PHARMA AB
Reel/Frame 046392/0920 →
Continuity (2)
Division 10063159 · Mar 26, 2002
Related Publication 20140007973A1 · Jan 9, 2014
Cited By (1)
US 12,345,352